Clinical Trials Logo

Clinical Trial Summary

Dapivirine Gel Rectal Safety and PK Study


Clinical Trial Description

A Randomized, Double Blind, Placebo-Controlled Phase 1 Safety and Pharmacokinetic Study of Dapivirine Gel (0.05%) Administered Rectally to HIV-1 Seronegative Adults ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03044379
Study type Interventional
Source International Partnership for Microbicides, Inc.
Contact
Status Withdrawn
Phase Phase 1
Start date September 29, 2015
Completion date November 2017